These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 12859398)

  • 1. Imiquimod to treat different cancers of the epidermis.
    Eklind J; Tartler U; Maschke J; Lidbrink P; Hengge UR
    Dermatol Surg; 2003 Aug; 29(8):890-6; discussion 896. PubMed ID: 12859398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imiquimod cream in the treatment of actinic keratoses.
    Persaud A; Lebwohl M
    J Am Acad Dermatol; 2002 Oct; 47(4 Suppl):S236-9. PubMed ID: 12271285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Solar keratosis: from precancerous lesion to pre-invasive squamous cell carcinoma--therapeutic approach with a bioinductive method].
    Oster-Schmidt C; Altmeyer P; Markus S
    J Dtsch Dermatol Ges; 2003 Oct; 1(10):790-6. PubMed ID: 16281815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imiquimod 5% cream for the treatment of actinic keratoses.
    Somani N; Rivers JK
    Skin Therapy Lett; 2005 Mar; 10(2):1-6. PubMed ID: 15986078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical effect of imiquimod 5% cream in the treatment of actinic keratosis.
    Persaud AN; Shamuelova E; Sherer D; Lou W; Singer G; Cervera C; Lamba S; Lebwohl MG
    J Am Acad Dermatol; 2002 Oct; 47(4):553-6. PubMed ID: 12271300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of cutaneous tumors with topical 5% imiquimod cream.
    Alessi SS; Sanches JA; Oliveira WR; Messina MC; Pimentel ER; Festa Neto C
    Clinics (Sao Paulo); 2009; 64(10):961-6. PubMed ID: 19841702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the effectiveness of imiquimod and 5-fluorouracil for the treatment of actinic keratosis: Critical review and meta-analysis of efficacy studies.
    Gupta AK; Davey V; Mcphail H
    J Cutan Med Surg; 2005 Oct; 9(5):209-14. PubMed ID: 16502198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating actinic keratoses with imiquimod.
    Dixon A
    Aust Fam Physician; 2007 May; 36(5):341-2. PubMed ID: 17492069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term clinical outcomes following treatment of actinic keratosis with imiquimod 5% cream.
    Lee PK; Harwell WB; Loven KH; Phillips TJ; Whiting DA; Andres KL; Lee JH
    Dermatol Surg; 2005 Jun; 31(6):659-64. PubMed ID: 15996416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imiquimod in the treatment of actinic keratoses and other intraepithelial neoplasms.
    Flowers F
    Int J Dermatol; 2002 May; 41 Suppl 1():12-5. PubMed ID: 12087813
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful treatment of actinic keratosis with imiquimod cream 5%: a report of six cases.
    Stockfleth E; Meyer T; Benninghoff B; Christophers E
    Br J Dermatol; 2001 May; 144(5):1050-3. PubMed ID: 11359396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and safety of imiquimod 5% cream in the treatment of actinic keratoses of the face, scalp, or hands and arms.
    Harrison LI; Skinner SL; Marbury TC; Owens ML; Kurup S; McKane S; Greene RJ
    Arch Dermatol Res; 2004 Jun; 296(1):6-11. PubMed ID: 15083310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical immunomodulation under systemic immunosuppression: results of a multicentre, randomized, placebo-controlled safety and efficacy study of imiquimod 5% cream for the treatment of actinic keratoses in kidney, heart, and liver transplant patients.
    Ulrich C; Bichel J; Euvrard S; Guidi B; Proby CM; van de Kerkhof PC; Amerio P; Rønnevig J; Slade HB; Stockfleth E
    Br J Dermatol; 2007 Dec; 157 Suppl 2(Suppl 2):25-31. PubMed ID: 18067628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5% topical imiquimod tolerance in transplant recipients.
    Ben M'barek L; Mebazaa A; Euvrard S; Frances C; Thervet E; Morel P; Menasché S; Legendre C; Lebbe C
    Dermatology; 2007; 215(2):130-3. PubMed ID: 17684375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imiquimod 3.75% cream (Zyclara) for the treatment of actinic keratoses.
    Quist SR; Gollnick HP
    Expert Opin Pharmacother; 2011 Feb; 12(3):451-61. PubMed ID: 21254950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imiquimod 5% cream for actinic keratosis.
    Perras C
    Issues Emerg Health Technol; 2004 Sep; (61):1-4. PubMed ID: 15382379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Actinic keratosis treated with an immune response modifier: a case report of six patients.
    Bianchi L; Campione E; Marulli GC; Costanzo A; Chimenti S
    Clin Exp Dermatol; 2003 Nov; 28 Suppl 1():39-41. PubMed ID: 14616813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical imiquimod: a review of its use in the management of anogenital warts, actinic keratoses, basal cell carcinoma and other skin lesions.
    Wagstaff AJ; Perry CM
    Drugs; 2007; 67(15):2187-210. PubMed ID: 17927284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New and emerging topical approaches for actinic keratoses.
    Del Rosso JQ
    Cutis; 2003 Oct; 72(4):273-6, 279. PubMed ID: 14604078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An open case series of patients with basal cell carcinoma treated with topical 5% imiquimod cream.
    Cowen E; Mercurio MG; Gaspari AA
    J Am Acad Dermatol; 2002 Oct; 47(4 Suppl):S240-8. PubMed ID: 12271286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.